Takeover

Acquirers

Biogen Inc.

Targets
1
Filings
2
Median premium
44%
First filing
Aug 11, 2023
Latest filing
Aug 22, 2023

Targets

CompanyScore before dealScore nowFilingsLatest
REATA PHARMACEUTICALS INC2 / 7—2Aug 22, 2023

Deal filings

FiledCompanyFormPricePremium
Aug 22, 2023REATA PHARMACEUTICALS INCDEFM14A$172.5044.44%
Aug 11, 2023REATA PHARMACEUTICALS INCPREM14A$172.5044.44%